Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.Drug Safety|February 14, 2024
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory TherapyEric B Cohen, Arie Regev, Anju Garg, et al.Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.The Journal of Infectious Diseases|March 7, 2006
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis CChihiro Morishima, Stephen J Polyak, Ranjit Ray, et al.Journal of Clinical Gastroenterology|February 28, 2013
Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatmentPatrick Marcellin, Antonio Craxi, Carlos E Brandao-Mello, et al.Journal of Viral Hepatitis|August 6, 2021
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort studyWilliam M Lee, Wendy C King, Harry L A Janssen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV InfectionMayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.Pageof 20